首页 > 最新文献

Clinical Journal of the American Society of Nephrology最新文献

英文 中文
Gender Differences in Citation Rate: An Analysis of Randomized Controlled Trials in Nephrology High-Impact Journals Over Two Decades. 引用率的性别差异:对二十年来肾脏病学高影响力期刊上随机对照试验的分析。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-06 DOI: 10.2215/CJN.0000000000000511
Qandeel H Soomro, Shuojohn Li, Angela McCarthy, Dalila Varela, Javaughn Ways, Amalya M Charytan, Colin Keane, Giana Ramos, Joey Nicholson, David M Charytan
{"title":"Gender Differences in Citation Rate: An Analysis of Randomized Controlled Trials in Nephrology High-Impact Journals Over Two Decades.","authors":"Qandeel H Soomro, Shuojohn Li, Angela McCarthy, Dalila Varela, Javaughn Ways, Amalya M Charytan, Colin Keane, Giana Ramos, Joey Nicholson, David M Charytan","doi":"10.2215/CJN.0000000000000511","DOIUrl":"10.2215/CJN.0000000000000511","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1453-1460"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556916/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141903486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study. 慢性肾功能不全队列研究中全谷物摄入量与健康结果的关系
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-14 DOI: 10.2215/CJN.0000000000000538
Dillon Winkelman, Julie Smith-Gagen, Casey M Rebholz, Orlando M Gutierrez, David E St-Jules
{"title":"Association of Intake of Whole Grains with Health Outcomes in the Chronic Renal Insufficiency Cohort Study.","authors":"Dillon Winkelman, Julie Smith-Gagen, Casey M Rebholz, Orlando M Gutierrez, David E St-Jules","doi":"10.2215/CJN.0000000000000538","DOIUrl":"10.2215/CJN.0000000000000538","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1435-1443"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556944/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983813","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole Grains, Refined Grains, and Diet Quality in Chronic Kidney Disease. 慢性肾脏病患者的全谷物、精制谷物和饮食质量。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.2215/CJN.0000000595
Susanne Fleig, Martin K Kuhlmann
{"title":"Whole Grains, Refined Grains, and Diet Quality in Chronic Kidney Disease.","authors":"Susanne Fleig, Martin K Kuhlmann","doi":"10.2215/CJN.0000000595","DOIUrl":"10.2215/CJN.0000000595","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"19 11","pages":"1365-1367"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556909/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142606178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cystatin C and Kidney Function Recovery in Patients Requiring Continuous KRT for Acute Kidney Injury. 胱抑素 C 与急性肾损伤需要持续肾脏替代疗法患者的肾功能恢复。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-21 DOI: 10.2215/CJN.0000000000000531
Sarah M Haeger, Kayo Okamura, Amy S Li, Zhibin He, Bryan D Park, Isadore M Budnick, North Foulon, Matthew Kennis, Rachel E Blaine, Makoto Miyazaki, Ruth Campbell, Diana I Jalal, James F Colbert, John T Brinton, Benjamin R Griffin, Sarah Faubel
{"title":"Cystatin C and Kidney Function Recovery in Patients Requiring Continuous KRT for Acute Kidney Injury.","authors":"Sarah M Haeger, Kayo Okamura, Amy S Li, Zhibin He, Bryan D Park, Isadore M Budnick, North Foulon, Matthew Kennis, Rachel E Blaine, Makoto Miyazaki, Ruth Campbell, Diana I Jalal, James F Colbert, John T Brinton, Benjamin R Griffin, Sarah Faubel","doi":"10.2215/CJN.0000000000000531","DOIUrl":"10.2215/CJN.0000000000000531","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1395-1404"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556902/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Association between Residential Segregation and Access to Kidney Transplantation: Evidence from a Multistate Cohort Study. 居住地隔离与肾移植机会之间的关系--来自多州队列研究的证据》(The Association Between Residential Segregation and Access to Kidney Transplantation - Evidence from a Multi-State Cohort Study)。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-08-26 DOI: 10.2215/CJN.0000000000000565
Jasmine Berry, Aubriana Perez, Mengyu Di, Chengcheng Hu, Stephen O Pastan, Rachel E Patzer, Jessica L Harding
{"title":"The Association between Residential Segregation and Access to Kidney Transplantation: Evidence from a Multistate Cohort Study.","authors":"Jasmine Berry, Aubriana Perez, Mengyu Di, Chengcheng Hu, Stephen O Pastan, Rachel E Patzer, Jessica L Harding","doi":"10.2215/CJN.0000000000000565","DOIUrl":"10.2215/CJN.0000000000000565","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1473-1484"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556903/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142074482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gender Equity in Academic Nephrology: Enough Talk, Now Is the Time to Act. 肾脏病学术界的性别平等:说得够多了,现在是行动的时候了。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-10-04 DOI: 10.2215/CJN.0000000585
Liz Lightstone
{"title":"Gender Equity in Academic Nephrology: Enough Talk, Now Is the Time to Act.","authors":"Liz Lightstone","doi":"10.2215/CJN.0000000585","DOIUrl":"10.2215/CJN.0000000585","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1368-1370"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142373467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities. 从家庭血液透析到可穿戴式血液透析:障碍、进展与机遇。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-01-08 DOI: 10.2215/CJN.0000000000000424
Matthew B Rivara, Jonathan Himmelfarb

Although the past two decades have seen substantial proportional growth of home hemodialysis in the United States, the absolute number of patients treated with home hemodialysis remains small. Currently available stationary hemodialysis devices for use in the home have inherent limitations that represent barriers for more widespread adoption by a larger proportion of individuals with kidney failure. These limitations include device weight and bulk, ergonomics considerations, technical complexity, vascular access challenges, and limited remote patient monitoring. Recent years have witnessed a resurgence in research and development of prototype wearable kidney replacement devices incorporating innovations in miniaturization, new biomaterials, and new methods for toxin clearance and dialysate regeneration. Recent work has built on five decades of incremental innovation in wearable dialysis concepts and prototypes, starting from the work by Kolff in the 1970s. Wearable dialysis devices that successfully overcome key persistent barriers to successful development and adoption of these technologies will radically reshape the landscape of kidney replacement therapies and have the potential to dramatically improve the lives of individuals living with kidney failure.

尽管在过去二十年中,美国家庭血液透析(HD)的比例有了大幅增长,但接受家庭血液透析治疗的患者绝对人数仍然很少。目前可用于家庭的固定式血液透析设备有其固有的局限性,这些局限性阻碍了更多的肾衰竭患者采用这种设备。这些限制包括设备重量和体积、人体工程学考虑、技术复杂性、血管通路挑战以及有限的远程患者监控。近年来,可穿戴式肾脏替代设备原型的研究和开发再次兴起,这些设备结合了微型化、新型生物材料以及毒素清除和透析液再生新方法等方面的创新。从 20 世纪 70 年代 Kolff 的研究开始,可穿戴透析设备的概念和原型已在五十年的渐进式创新基础上取得了长足进步。可穿戴透析设备如能成功克服阻碍这些技术成功开发和应用的主要顽固障碍,将从根本上重塑肾脏替代疗法的格局,并有可能极大地改善肾衰竭患者的生活。
{"title":"From Home to Wearable Hemodialysis: Barriers, Progress, and Opportunities.","authors":"Matthew B Rivara, Jonathan Himmelfarb","doi":"10.2215/CJN.0000000000000424","DOIUrl":"10.2215/CJN.0000000000000424","url":null,"abstract":"<p><p>Although the past two decades have seen substantial proportional growth of home hemodialysis in the United States, the absolute number of patients treated with home hemodialysis remains small. Currently available stationary hemodialysis devices for use in the home have inherent limitations that represent barriers for more widespread adoption by a larger proportion of individuals with kidney failure. These limitations include device weight and bulk, ergonomics considerations, technical complexity, vascular access challenges, and limited remote patient monitoring. Recent years have witnessed a resurgence in research and development of prototype wearable kidney replacement devices incorporating innovations in miniaturization, new biomaterials, and new methods for toxin clearance and dialysate regeneration. Recent work has built on five decades of incremental innovation in wearable dialysis concepts and prototypes, starting from the work by Kolff in the 1970s. Wearable dialysis devices that successfully overcome key persistent barriers to successful development and adoption of these technologies will radically reshape the landscape of kidney replacement therapies and have the potential to dramatically improve the lives of individuals living with kidney failure.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1488-1495"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139378727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise and Cognition in People with Chronic Kidney Disease. 慢性肾病患者的运动与认知能力
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 DOI: 10.2215/CJN.0000000589
Nicole Scholes-Robertson
{"title":"Exercise and Cognition in People with Chronic Kidney Disease.","authors":"Nicole Scholes-Robertson","doi":"10.2215/CJN.0000000589","DOIUrl":"10.2215/CJN.0000000589","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":"19 11","pages":"1357-1358"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142605221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease. 矿物质皮质激素受体拮抗剂在非糖尿病慢性肾病和肾小球疾病中的潜在作用
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-22 DOI: 10.2215/CJN.0000000000000540
Teena Zachariah, Jai Radhakrishnan

Glomerular disease is a leading cause of CKD and ESKD. Although diabetic kidney disease is the most common cause of glomerular disease, nondiabetic causes include malignancy, systemic autoimmune conditions, drug effects, or genetic conditions. Nondiabetic glomerular diseases are rare diseases, with a paucity of high-quality clinical trials in this area. Furthermore, late referral can result in poor patient outcomes. This article reviews the current management of nondiabetic glomerular disease and explores the latest developments in drug treatment in this area. Current treatment of nondiabetic glomerular disease aims to manage complications (edema, hypertension, proteinuria, hyperlipidemia, hypercoagulability, and thrombosis) as well as target the underlying cause of glomerular disease. Treatment options include renin-angiotensin-aldosterone system inhibitors, statins/nonstatin alternatives, loop diuretics, anticoagulation agents, immunosuppressives, and lifestyle and dietary modifications. Effective treatment of nondiabetic glomerular disease is limited by heterogeneity and a lack of understanding of the disease pathogenesis. Sodium-glucose cotransporter-2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs, such as finerenone), with their broad anti-inflammatory and antifibrotic effects, have emerged as valuable therapeutic options for a range of cardiorenal conditions, including CKD. ns-MRAs are an evolving drug class of particular interest for the future treatment of nondiabetic glomerular disease, and there is evidence that these agents may improve kidney prognosis in various subgroups of patients with CKD. The benefits offered by ns-MRAs may present an opportunity to reduce the progression of CKD from a spectrum of glomerular disease. Several novel ns-MRA are in clinical development for both diabetic and nondiabetic CKD.

摘要:肾小球疾病是慢性肾脏病(CKD)和终末期肾脏病的主要病因。虽然糖尿病肾病是导致肾小球疾病的最常见原因,但非糖尿病原因包括恶性肿瘤、系统性自身免疫性疾病、药物作用或遗传性疾病。非糖尿病肾小球疾病是罕见疾病,该领域的高质量临床试验很少。此外,转诊过晚可能导致患者预后不佳。本手稿回顾了当前非糖尿病肾小球疾病的治疗方法,并探讨了该领域药物治疗的最新进展。目前治疗非糖尿病肾小球疾病的目的是控制并发症(水肿、高血压、蛋白尿、高脂血症、高凝状态和血栓形成),并针对肾小球疾病的根本原因进行治疗。治疗方案包括肾素-血管紧张素-醛固酮系统抑制剂、他汀类药物/非他汀类药物替代品、襻利尿剂、抗凝药物、免疫抑制剂以及生活方式和饮食调整。非糖尿病肾小球疾病的有效治疗受到异质性和对疾病发病机制缺乏了解的限制。钠-葡萄糖共转运体-2 抑制剂和非甾体类矿物皮质激素受体拮抗剂(ns-MRAs,如非格列酮)具有广泛的抗炎和抗纤维化作用,已成为包括 CKD 在内的一系列心肾疾病的重要治疗选择。ns-MRAs是一种不断发展的药物类别,在未来治疗非糖尿病肾小球疾病方面具有特殊意义,有证据表明,这些药物可以改善不同亚群慢性肾脏病患者的肾脏预后。ns-MRA 带来的益处可能为减少肾小球疾病谱中的慢性肾功能衰竭的进展提供了机会。目前有几种新型 ns-MRA 正处于临床开发阶段,可用于治疗糖尿病和非糖尿病性 CKD。
{"title":"Potential Role of Mineralocorticoid Receptor Antagonists in Nondiabetic Chronic Kidney Disease and Glomerular Disease.","authors":"Teena Zachariah, Jai Radhakrishnan","doi":"10.2215/CJN.0000000000000540","DOIUrl":"10.2215/CJN.0000000000000540","url":null,"abstract":"<p><p>Glomerular disease is a leading cause of CKD and ESKD. Although diabetic kidney disease is the most common cause of glomerular disease, nondiabetic causes include malignancy, systemic autoimmune conditions, drug effects, or genetic conditions. Nondiabetic glomerular diseases are rare diseases, with a paucity of high-quality clinical trials in this area. Furthermore, late referral can result in poor patient outcomes. This article reviews the current management of nondiabetic glomerular disease and explores the latest developments in drug treatment in this area. Current treatment of nondiabetic glomerular disease aims to manage complications (edema, hypertension, proteinuria, hyperlipidemia, hypercoagulability, and thrombosis) as well as target the underlying cause of glomerular disease. Treatment options include renin-angiotensin-aldosterone system inhibitors, statins/nonstatin alternatives, loop diuretics, anticoagulation agents, immunosuppressives, and lifestyle and dietary modifications. Effective treatment of nondiabetic glomerular disease is limited by heterogeneity and a lack of understanding of the disease pathogenesis. Sodium-glucose cotransporter-2 inhibitors and nonsteroidal mineralocorticoid receptor antagonists (ns-MRAs, such as finerenone), with their broad anti-inflammatory and antifibrotic effects, have emerged as valuable therapeutic options for a range of cardiorenal conditions, including CKD. ns-MRAs are an evolving drug class of particular interest for the future treatment of nondiabetic glomerular disease, and there is evidence that these agents may improve kidney prognosis in various subgroups of patients with CKD. The benefits offered by ns-MRAs may present an opportunity to reduce the progression of CKD from a spectrum of glomerular disease. Several novel ns-MRA are in clinical development for both diabetic and nondiabetic CKD.</p>","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1499-1512"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556932/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141749572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exercise and Cognitive Function in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Efficacy and Harms. 运动与认知功能 慢性肾脏病:疗效与危害的系统回顾与元分析》。
IF 8.5 1区 医学 Q1 UROLOGY & NEPHROLOGY Pub Date : 2024-11-01 Epub Date: 2024-07-31 DOI: 10.2215/CJN.0000000000000533
Ellen Bradshaw, Abdulfattah Alejmi, Gabriella Rossetti, Giovanni D'Avossa, Jamie Hugo Macdonald
{"title":"Exercise and Cognitive Function in Chronic Kidney Disease: A Systematic Review and Meta-Analysis of Efficacy and Harms.","authors":"Ellen Bradshaw, Abdulfattah Alejmi, Gabriella Rossetti, Giovanni D'Avossa, Jamie Hugo Macdonald","doi":"10.2215/CJN.0000000000000533","DOIUrl":"10.2215/CJN.0000000000000533","url":null,"abstract":"","PeriodicalId":50681,"journal":{"name":"Clinical Journal of the American Society of Nephrology","volume":" ","pages":"1461-1472"},"PeriodicalIF":8.5,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11556908/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical Journal of the American Society of Nephrology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1